SOURCE: Thomson Reuters Corporation

Thomson Reuters Corporation

May 08, 2011 21:00 ET

Reuters Health Summit -- May 9-12 -- FDA Official and Leading CEOs From Health Corporations to Discuss the Outlook for Healthcare

Reuters Exclusive Health Summit Begins Monday, May 9, 2011 in New York

Continuous Coverage Available on

NEW YORK, NY--(Marketwire - May 8, 2011) - Some of the world's most prominent CEOs and top executives from leading healthcare companies, as well as the FDA's Center for Drug Evaluation and Research Director Janet Woodcock, will meet with Reuters journalists in a series of exclusive closed interviews to discuss the current issues and outlook for the business of healthcare at the annual Reuters Health Summit on May 9-12. Exclusive stories from the closed on-the-record sessions will be posted online at

The drug industry's business model is unraveling after years of bankable growth. The biggest pharmaceutical names are losing billions of dollars in sales to generic versions of their best-selling treatments, device makers are seeing consumers postpone costly medical procedures in a weak economy and biotechnology companies are battling efforts to trim prices on their specialized drugs.

To cope with the changes, some are diversifying their businesses with multibillion dollar acquisitions, while others are slashing research budgets or dramatically shrinking their operations. Health insurers and companies that negotiate drug pricing aim to capitalize on these trends, as well as on a new U.S. healthcare law that will extend coverage to millions more Americans. And in the midst of these strategic changes, the medical community still awaits exciting new therapies for multiple sclerosis, hepatitis C and cancer from these corporate laboratories.

Some of the healthcare industry's most prominent executives and officials will discuss their strategies for change in a series of on-the-record interviews in New York at the 2011 Reuters Health Summit. The event will generate exclusive stories, investable insights, online videos and blog postings, immediately available only to Thomson Reuters clients during the Summit.

Some key interviews will air live exclusively on Reuters Insider -- a personalized video experience. Visit

Guests speaking at the Reuters Health Summit will include:

  • AstraZeneca CEO David Brennan;
  • Biogen CEO George Scangos;
  • Allergan CEO David Pyott;
  • Medco CEO David Snow;
  • U.S. Food and Drug Administration's Center for Drug Evaluation and Research Director Janet Woodcock;
  • Sanofi-Aventis CEO Chris Viebacher;
  • Celgene CEO Bob Hugin;
  • Covidien Incoming CEO Jose Almeida;
  • GlaxoSmithKline CFO Simon Dingemans;
  • Novartis CFO Jon Symonds;
  • Shire CEO Angus Russell;
  • Novo Nordisk CEO Lars Sorensen;
  • Becton Dickinson & Co CEO Ed Ludwig; and
  • Bain Head of Americas Healthcare Practice Tim van Biesen.

Learn more about healthcare information resources from Thomson Reuters. Contact Tracy Guo at about specific healthcare solutions available to financial firms.

Follow us on Twitter@Reuters_Summits

Reuters Summits bring together top executives from key industries in exclusive sessions with Reuters News global teams of specialist journalists. During the course of Reuters Summits, exclusive news stories and video interviews are posted on, providing valuable insight into specific companies, business sectors, and economies.


Reuters Summits are roundtable interviews, not conferences, and are closed to other media attending. Media wishing to use interview text, video and audio can use Reuters News material with proper attribution to the Reuters Health Summit, with 'told Reuters' in second references.

For continuous coverage of this summit, click here:


An RSS feed is available for use by industry blogs, newsletters and websites.
Click below to use the

Contact Information

    Nina Andrikian (New York)
    Reuters News